As of Sep 27
| +0.35 / +0.81%|
The 13 analysts offering 12-month price forecasts for Metlife have a median target of 49.00, with a high estimate of 54.00 and a low estimate of 44.00. The median estimate represents a +12.00% increase from the last price of 43.75.
The current consensus among 17 polled investment analysts is to Buy stock in Metlife. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.